Qat (Khat) Chewing‑Related Oral Leukoplakia
Overview
Oral leukoplakia is a white, plaque‑like lesion that cannot be rubbed off and cannot be attributed to any other diagnosable condition. When the lesion is linked to the chronic chewing of Catha edulis (commonly known as qat, khat, or chewing‑stick), it is referred to as qat‑related oral leukoplakia (QROL). The habit of chewing fresh qat leaves, which contains the stimulant cathinone, is prevalent in East Africa (especially Ethiopia, Somalia, Djibouti, and Kenya) and parts of the Arabian Peninsula.
Key points:
- QROL most commonly appears on the buccal mucosa, gingiva, and soft palate—areas that are in direct contact with the qat leaf.
- Population‑based studies in Ethiopia estimate a prevalence of oral leukoplakia of 1.5‑4 % among regular qat chewers, compared with < 0.5 % in non‑chewers.[1]
- Both men and women chew qat, but prevalence is higher in men (70‑80 % of chewers) because of cultural norms.
- The condition is considered potentially malignant; about 5‑10 % of all oral leukoplakias transform into oral squamous cell carcinoma (OSCC) over 5‑10 years, with higher rates reported in qat chewers who also smoke or drink alcohol.[2]
Symptoms
Oral leukoplakia is often asymptomatic, especially in early stages. When symptoms appear, they may include:
- White patch or plaque – persistent, well‑demarcated, often slightly raised.
- Texture change – rough, wrinkled, or “leathery” surface.
- Localized irritation – burning, itching, or mild pain when the area contacts food or the qat leaf.
- Ulceration – if the lesion becomes dysplastic or infected, a sore may develop.
- Difficulty swallowing (dysphagia) – rare, occurs only with large lesions on the oropharynx.
- Altered taste – metallic or bitter taste, especially after chewing qat.
- Bleeding – uncommon; suggests secondary trauma or malignant change.
Because many lesions are painless, routine dental examinations are essential for early detection.
Causes and Risk Factors
Primary cause
Chronic mechanical irritation and chemical exposure from qat leaves:
- **Mechanical trauma** – the act of holding a wad of fresh leaves against the buccal mucosa for 3‑5 hours results in continuous rubbing and pressure.
- **Chemical irritation** – cathinone, tannins, and other alkaloids in qat act as local irritants and may promote epithelial hyperplasia.
Additional risk factors
- Duration and frequency of chewing – daily use for ≥5 years increases risk dramatically.
- Concurrent tobacco use – smoking or smokeless tobacco synergistically raises malignant transformation risk.
- Alcohol consumption – heavy drinking further compounds risk.
- Age – lesions are more common after age 30, when cumulative exposure is higher.
- Genetic susceptibility – polymorphisms in genes involved in xenobiotic metabolism (e.g., GSTM1 null) have been linked to higher leukoplakia rates in qat chewers.[3]
- Nutritional deficiencies – low intake of vitamins A, C, and E may impair mucosal healing.
Diagnosis
Diagnosing QROL follows the same pathway as other oral leukoplakias, with a focus on the patient’s chewing habit.
Clinical examination
- Visual inspection under good lighting; use of a tongue depressor and a small mirror.
- Palpation to assess thickness, induration, or fixation to underlying tissue.
- Documentation with intra‑oral photographs.
Adjunctive tests
- Toluidine blue staining – highlights areas of dysplasia; positive staining warrants biopsy.
- Velscope (fluorescence imaging) – loss of autofluorescence may suggest malignant change.
Definitive diagnosis
A incisional or excisional biopsy is required to determine histopathology:
- Hyperkeratosis with or without mild dysplasia (most common).
- Moderate‑to‑severe dysplasia or carcinoma in situ – indicates higher malignant potential.
Laboratory work‑up (optional)
- Complete blood count (CBC) – to rule out anemia or infection.
- Serum vitamin levels – identify deficiencies that may delay healing.
- DNA ploidy analysis or molecular markers (e.g., p53 mutation) – used in research settings to stratify cancer risk.
Treatment Options
Treatment is multimodal, aiming to remove the lesion, eliminate the offending habit, and monitor for recurrence.
Lifestyle modification
- Cease qat chewing – the most critical step; cessation reduces mechanical irritation and chemical exposure.
- Smoking cessation and reduction of alcohol intake are strongly advised.
- Adopt a balanced diet rich in fruits, vegetables, and whole grains to improve mucosal health.
Medical / Pharmacologic interventions
- Topical corticosteroids (e.g., clobetasol propionate 0.05 % gel) – may reduce inflammatory components in hyperkeratotic lesions.
- Vitamin A (retinoids) – oral isotretinoin 0.5‑1 mg/kg/day for 2‑3 months has shown regression in some leukoplakias, but side‑effects limit long‑term use.[4]
- Antioxidant supplements (vitamins C & E, beta‑carotene) – adjunctive role; evidence is modest.
Surgical / procedural options
- Excisional biopsy – removes the lesion and provides pathology; preferred for small, well‑defined patches.
- Laser ablation (CO₂ or Nd:YAG) – precise removal with minimal bleeding; useful for larger or multifocal lesions.
- Electrocautery – alternative when laser is unavailable.
- Cryotherapy – liquid nitrogen freezes the lesion; less commonly used.
Any surgical method should be followed by regular post‑operative surveillance.
Follow‑up schedule
- First review 4‑6 weeks post‑treatment.
- Then every 3‑6 months for the first 2 years.
- Annual review thereafter, or sooner if new lesions appear.
Living with Qat (khat) Chewing‑Related Oral Leukoplakia
Managing QROL involves more than treating the lesion; it requires day‑to‑day strategies to protect oral health.
- Oral hygiene – brush twice daily with a soft‑bristled brush, floss, and use an alcohol‑free fluoride mouthwash.
- Regular dental visits – at least twice a year for professional cleaning and examination.
- Moisturizing the mouth – sugar‑free gum or lozenges can stimulate saliva, reducing dryness caused by habit cessation.
- Dietary adjustments – incorporate foods high in antioxidants (berries, leafy greens) and limit spicy or acidic foods that may irritate the mucosa.
- Stress management – many users chew qat for its stimulant effect. Explore alternatives such as exercise, meditation, or counseling.
- Support groups – community or online groups for former qat chewers provide peer encouragement.
- Monitoring – keep a simple log of any new white patches, pain, or changes in existing lesions, and report them promptly.
Prevention
Preventing QROL centers on eliminating the inciting factor and adopting protective oral habits.
- Avoid qat chewing – the most effective preventive measure.
- Do not substitute qat with tobacco products; both increase malignancy risk.
- Maintain optimal oral hygiene and schedule routine dental check‑ups.
- Consume a diet rich in vitamins A, C, and E; consider a daily multivitamin if dietary intake is insufficient.
- Stay hydrated – adequate saliva flow helps mucosal turnover.
- Screen high‑risk individuals (daily chewers > 5 years) annually for early leukoplakia.
Complications
If QROL is left untreated, several complications can arise:
- Malignant transformation – progression to oral squamous cell carcinoma (OSCC); risk climbs to 10‑15 % in high‑risk chewers with dysplasia.[2]
- Secondary infection – ulcerated lesions can become colonized by bacteria or fungi.
- Functional impairment – large plaques may interfere with speech, mastication, or swallowing.
- Cosmetic concerns – persistent white patches may affect self‑esteem.
- Psychological impact – anxiety about cancer risk can affect mental health.
When to Seek Emergency Care
- Sudden, severe mouth or facial pain that does not improve with over‑the‑counter analgesics.
- Rapidly enlarging lesion that becomes ulcerated, bleeds profusely, or shows a foul odor.
- Difficulty breathing or swallowing (signs of airway compromise).
- Unexplained weight loss, persistent fever, or night sweats associated with oral lesions.
- Swelling of the neck or jaw that restricts mouth opening (trismus).
These symptoms may indicate an aggressive infection, malignant transformation, or another serious condition that requires urgent evaluation.
References
- [1] Alemu, A. et al. “Prevalence of Oral Leukoplakia Among Qat Chewers in Ethiopia.” East African Medical Journal, 2022.
- [2] Warnakulasuriya, S. “Oral Leukoplakia: Clinical Aspects and Management.” Journal of Oral Pathology & Medicine, 2021.
- [3] Hassan, M. et al. “Genetic Polymorphisms and Susceptibility to Qat‑Associated Oral Lesions.” International Journal of Cancer, 2020.
- [4] Llovet, J. et al. “Systemic Retinoids for Oral Premalignant Lesions: A Systematic Review.” Cochrane Database of Systematic Reviews, 2021.
- World Health Organization. “Khat (Catha edulis) Fact Sheet.” WHO, 2023.
- Mayo Clinic. “Leukoplakia.” Mayo Clinic, accessed May 2024.